Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Neoplasms 2Neoplasm Metastasis 2Pancreatic Neoplasms 1Pain 1Multiple Myeloma 1Lymphoma 1Hematologic Neoplasms 1Cancer Pain 1Adenocarcinoma 1

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × Sodium Bicarbonate × Clear all
NCT02531919 2016-04-13

Extended Use of Sodium Bicarbonate in Patients With Cancer

University of Arizona

Phase 1 Completed
15 enrolled
Tumor-Agnostic

Neoplasms

NCT01846429 2015-06-04

Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Terminated
9 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cancer Pain, Lymphoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Pain, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡